EUVIMEDEUVIMED entdecken
Crossref

Selective and Orally Bioavailable Dipeptidyl Peptidase 9 Inhibitors with Potent Pyroptosis Induction Properties

Nicolò Filippi iD, Kathleen Mertens iD, Joni De Loose, Siham Benramdane, Robin Hermans, Margarida Espadinha, Laura Dirkx, Pim-Bart Feijens, Vanesa Nozal, Emile Verhulst, Sarah Peeters, Tiphanie Gomard und 6 weitere

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c02049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Nicolò Filippi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk 2610, Belgium. Hauptthemen laut MEDLINE: Pyroptosis, Dipeptidyl-Peptidases and Tripeptidyl-Peptidases. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Universiteit Antwerpen, H2020 Marie Sklodowska-Curie Actions, Fonds Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dipeptidyl peptidase 9 (DPP9) is a key regulator of pyroptosis in leukocytes. DPP9-targeting inhibitors have been reported to selectively induce pyroptosis in human acute myeloid leukemia (AML) cells and work synergistically with non-nucleoside reverse transcriptase inhibitors (NNRTIs) to kill HIV-1-infected lymphocytes. Here, we report structure-activity relationship data for a novel series of low nanomolar DPP9 inhibitors with unprecedented pyroptosis-inducing potency and kinetics. They have substantial DPP9-to-DPP8 selectivity and full selectivity over other related peptidases, including DPP4. The selected compound 6e was administered to healthy rats and demonstrated high oral bioavailability, along with a long in vivo and microsomal half-life. Finally, we also investigated the pyroptosis induction potential in HIV-1-infected T-lymphocytes. These new compounds have the potential to become important research tools and support further progress in DPP9's therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisDipeptidyl-Peptidases and Tripeptidyl-PeptidasesAnimalsHumansStructure-Activity RelationshipAdministration, OralRatsBiological AvailabilityMaleRats, Sprague-DawleyHalf-Life

Substanzen

DPP9 protein, humanDipeptidyl-Peptidases and Tripeptidyl-Peptidases

Autor:innen und Institutionen

  • Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk 2610, Belgium.
  • Laboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk 2610, Belgium.
  • Molecular, Structural and Translational Research group, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, University of Leuven, Herestraat 49, Leuven 3000, Belgium.
  • Laboratory of Microbiology, Parasitology and Hygiene, Department of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, Wilrijkcity 2610, Belgium.
  • Institut de Duve, Université Catholique de Louvain, Brussels 1200, Belgium.
  • Infla-Med Centre of Excellence, University of Antwerp, Universiteitsplein 1, Wilrijk 2610, Belgium.

ORCID-Profile: Nicolò Filippi, Kathleen Mertens, Koen Augustyns, Guy Caljon, Ingrid De Meester, Pieter Van der Veken

Förderung

  • Universiteit Antwerpen
  • H2020 Marie Sklodowska-Curie Actions
  • Fonds Wetenschappelijk Onderzoek
  • Fonds De La Recherche Scientifique - FNRS

Zitieren

APA

Filippi, N., Mertens, K., De Loose, J., Benramdane, S., Hermans, R., Espadinha, M., Dirkx, L., Feijens, P. B., Nozal, V., Verhulst, E., Peeters, S., Gomard, T., Corthaut, S., Augustyns, K., Caljon, G., Schols, D., De Meester, I., & Van der Veken, P. (2025). Selective and Orally Bioavailable Dipeptidyl Peptidase 9 Inhibitors with Potent Pyroptosis Induction Properties. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02049

Vancouver

Filippi N, Mertens K, De Loose J, Benramdane S, Hermans R, Espadinha M, et al. Selective and Orally Bioavailable Dipeptidyl Peptidase 9 Inhibitors with Potent Pyroptosis Induction Properties. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c02049

BibTeX
@article{Filippi2025,
  author = {Filippi, Nicolò and Mertens, Kathleen and De Loose, Joni and Benramdane, Siham and Hermans, Robin and Espadinha, Margarida and Dirkx, Laura and Feijens, Pim-Bart and Nozal, Vanesa and Verhulst, Emile and Peeters, Sarah and Gomard, Tiphanie and Corthaut, Sam and Augustyns, Koen and Caljon, Guy and Schols, Dominique and De Meester, Ingrid and Van der Veken, Pieter},
  title = {Selective and Orally Bioavailable Dipeptidyl Peptidase 9 Inhibitors with Potent Pyroptosis Induction Properties},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c02049}
}
Kostenlos starten →